SMITH
ET AL., ACC/AHA GUIDELINES FOR PERCUTANEOUS CORONARY
INTERVENTION
(REVISION OF THE 1993 PTCA GUIDELINES)
JACC VOL. 37, NO. 8, JUNE 2001:2239i-lxvi
ACC/AHA
Guidelines for Percutaneous Coronary Intervention (Revision
of the 1993 PTCA Guidelines)
A
Report of the American College of Cardiology/American
Heart Association Task Force on Practice Guidelines
(Committee to Revise the 1993 Guidelines for Percutaneous
Transluminal Coronary Angioplasty)
Endorsed
by the Society for Cardiac Angiography and Interventions
Figures
and Tables
Figure
1. Frequency of Device Use in the SCA&I Registry
Figure 2. Balloon Stent vs. Balloon
Angioplasty in Coronary Artery Disease
Figure 3. Mortality at the end
of study in all the trials comparing primary PTCA with
thombolytic drug treatment.
Figure 4. Death or nonfatal myocardial
infarction outcomes at 30 days in 10 ramdomized, placebo-controlled
trials of GP IIb/IIIa blockers
Figure
5. AHA Guide to Comprehensive Risk Reduction for
Patients with Coronary and Other Vascular Disease
Table 1. Definitions of Procedural
Complications
Table 2. Unadjusted In-Hospital
Outcome Trends Following Percutaneous Intervensions
Table 3. Selected Trials of
Pharmocologic and Mechanical Approaches to Limit Restenosis
Table 4. Studies Comparing
Balloon Angioplasty with Stents for Native Coronary
Artery Lesions
Table 5. Lesion Classification
System
Table 6. Clinical Risk Factors
Associated with In-Hospital Adverse Events
Table 7. Gender-Specific Late
Mortality Risk
Table 8. Probability of Success,
Complications, and Restenosis After Balloon Angioplasty
or Stenting Patients Following Coronary Bypass Surgery
Table 9. Procedural Outcomes
Associated with Specific Technologies
Table 10. Summary of Randomized
Trials of PTCA and CBGA for Multivessel Disease
Table 11. PCI Comparison with
Medical Therapy
Table 12. Key Components of
a Quality Assurance Program
Table
13. Considerations for the Assessment and Maintenance
of Proficiency in Coronary Interventional Procedures
Table
14. Recommendations for PCI Institutional and Operator
Volumes at Centers with Onsite Cardiac Surgery
Table
15. Criteria for the Performance of Primary Angioplasty
at Hospitals without Onsite Cardiac Surgery
Table
16. Patients Selection for Angioplasty and Emergency
Aortocoronary Bypass at Hospitals without Onsite Cardiac
Surgery
Table
17. Recommendations for PCI with and without Onsite Cardiac Surgery
Table
18. Provider Checklist: Key Areas for Consideration
Table
19. Recommendations for PCI in Asymptomatic or Class
I Angina Patients
Table
20. Noninvasive Risk Stratification: High Risk (>3% annual mortality rate)
Table
21. Recommendations for PCI in Moderate or Severe
Symptomatic, Class II-IV Angina, Unstable Angina, or
Non-ST-Elevations MI Patients
Table
22. Invasive vs. Conservative Strategies in Unstable Angina Patients
Table
23. Studies Comparing PTCA with Stents in Acute Myocardial Infarction
Table
24. Contraindications and Cautions for Thrombolytic Use in Myocardial Infarction
Table
25. Recommendations for Primary PCA in Acute Transmural
MRI Patients as an Alternative to Thrombolysis
Table
26. Recommendations for PCI After Thrombolysis
Table
27. Recommendations for PCI During Subsequent Hospital
Management After Acute Therapy for AMI Including Primary
PCI
Table
28. Recommendations for PCI with Prior CABG
Table
29. Recommendations for Coronary Intravascular Ultrasound (IVUS)
Table
30. Recommendations for Intracoronary Physiologic
Measurements (Doppler Ultrasound, Fractional Flow Reserve
Table
31. Recommendations for Pharmocologic Management of Patients Undergoing PCI
Table
32. Predictive Value of Exercise Electrocardiographic
Testing for Identification of Restenosis After PTCA
Table
33. Exclusion Criteria for Invasive Cardiac Procedures in Settings without Full Support Services
Table
34. Summarizes Coronary Angioplasty Studies in Heart Transplant Patients
© 2001 by the American College of Cardiology
and American Heart Association
|
